Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW): Long Term Thesis Unchanged - Stifel

October 25, 2017 7:01 AM
Stifel analyst, Rick Wise, reiterated his Buy rating on shares of Edwards Lifesciences (NYSE: EW) but expects the stock to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles